Citation Impact
Citing Papers
Multiregion Whole-Exome Sequencing Uncovers the Genetic Evolution and Mutational Heterogeneity of Early-Stage Metastatic Melanoma
2016
Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition
2013 StandoutScience
Nuclear Janus-Activated Kinase 2/Nuclear Factor 1-C2 Suppresses Tumorigenesis and Epithelial-to-Mesenchymal Transition by Repressing Forkhead Box F1
2010
Nucleic acid detection with CRISPR-Cas13a/C2c2
2017 StandoutScience
Aldehyde Dehydrogenase 1–Positive Cancer Stem Cells Mediate Metastasis and Poor Clinical Outcome in Inflammatory Breast Cancer
2009
Subtype-Specific Metagene-Based Prediction of Outcome after Neoadjuvant and Adjuvant Treatment in Breast Cancer
2015
Hypoxia‐inducible factors: coupling glucose metabolism and redox regulation with induction of the breast cancer stem cell phenotype
2016 StandoutNobel
Hypoxia-inducible factors and RAB22A mediate formation of microvesicles that stimulate breast cancer invasion and metastasis
2014 StandoutNobel
Epithelial–mesenchymal transition in breast cancer correlates with high histological grade and triple‐negative phenotype
2012
Palindromic amplification of the ERBB2 oncogene in primary HER2-positive breast tumors
2017
Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update
2013
Improved prognostic classification of breast cancer defined by antagonistic activation patterns of immune response pathway modules
2010
Cancer–stromal cell interactions mediated by hypoxia-inducible factors promote angiogenesis, lymphangiogenesis, and metastasis
2012 StandoutNobel
Regulation of the breast cancer stem cell phenotype by hypoxia-inducible factors
2015 StandoutNobel
Breast cancer stem cells: implications for therapy of breast cancer
2008
Hallmarks of Cancer: The Next Generation
2011 Standout
Wnt/β-Catenin Pathway Activation Is Enriched in Basal-Like Breast Cancers and Predicts Poor Outcome
2010
Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update
2013 Standout
Cell-free circulating tumor DNA in cancer
2016
Prognostic impact of ALDH1 in breast cancer: a story of stem cells and tumor microenvironment
2009
Triple-Negative Breast Cancer: Distinguishing between Basal and Nonbasal Subtypes
2009
Gene Modules and Response to Neoadjuvant Chemotherapy in Breast Cancer Subtypes: A Pooled Analysis
2012
Triple-Negative Breast Cancer
2010 Standout
Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update
2018 Standout
Breast cancer stem cells: treatment resistance and therapeutic opportunities
2011
Cancer Invasion and the Microenvironment: Plasticity and Reciprocity
2011 Standout
Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits
2009 Standout
A view on drug resistance in cancer
2019 StandoutNature
Inflammation and Cancer: Triggers, Mechanisms, and Consequences
2019 Standout
Contribution of platelets to tumour metastasis
2011 Standout
Hypoxia Regulates CD44 and Its Variant Isoforms through HIF-1α in Triple Negative Breast Cancer
2012 StandoutNobel
Breast Cancer Stem Cells: Current Advances and Clinical Implications
2015
Molecular mechanisms of epithelial–mesenchymal transition
2014 Standout
EMT and Dissemination Precede Pancreatic Tumor Formation
2012 Standout
Nuclear receptor coregulators as a new paradigm for therapeutic targeting
2010
WNT signalling pathways as therapeutic targets in cancer
2012 Standout
Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future
2017 Standout
Cancer drug resistance: an evolving paradigm
2013 Standout
Lethal Mutagenesis of Hepatitis C Virus Induced by Favipiravir
2016 StandoutNobel
Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease
2016 Standout
Current and future perspectives of liquid biopsies in genomics-driven oncology
2018 Standout
Tissue factor in cancer progression and angiogenesis
2010
Immune parameters affecting the efficacy of chemotherapeutic regimens
2011
Multimodal biomedical AI
2022 Standout
Immunity, Inflammation, and Cancer
2010 Standout
Unraveling the therapeutic potential of the Hedgehog pathway in cancer
2013 Standout
Phenotypic Plasticity: Driver of Cancer Initiation, Progression, and Therapy Resistance
2018
Liquid biopsies come of age: towards implementation of circulating tumour DNA
2017 Standout
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
2013 Standout
Broadening horizons: the role of ferroptosis in cancer
2021 Standout
Emerging Biological Principles of Metastasis
2017 Standout
Therapeutic Implications of Cellular Heterogeneity and Plasticity in Breast Cancer
2015
EMT: 2016
2016 Standout
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
2011 Standout
The immune contexture in human tumours: impact on clinical outcome
2012 Standout
Breast Cancer Prognosis and Occult Lymph Node Metastases, Isolated Tumor Cells, and Micrometastases
2010
G9a interacts with Snail and is critical for Snail-mediated E-cadherin repression in human breast cancer
2012
GOBO: Gene Expression-Based Outcome for Breast Cancer Online
2011
The CD44+/CD24− phenotype relates to ‘triple-negative’ state and unfavorable prognosis in breast cancer patients
2010
Lymphangiogenesis and lymphatic metastasis in breast cancer
2009
Cancer stem cells: mirage or reality?
2009
The secret ally: immunostimulation by anticancer drugs
2012
The PI3K Pathway in Human Disease
2017 Standout
Regulatory networks defining EMT during cancer initiation and progression
2013 Standout
Deconstructing the molecular portraits of breast cancer
2010
Immunogenic cell death and DAMPs in cancer therapy
2012 Standout
Developmental signaling pathways in cancer stem cells of solid tumors
2012
Selectively Sensitizing Malignant Cells to Photothermal Therapy Using a CD44-Targeting Heat Shock Protein 72 Depletion Nanosystem
2016
Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer
2018 Standout
Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells
2009
A Perspective on Cancer Cell Metastasis
2011 StandoutScience
Breast Cancer Treatment
2019 Standout
Hypoxia-inducible factor 1-dependent expression of adenosine receptor 2B promotes breast cancer stem cell enrichment
2018 StandoutNobel
Diminished viral replication and compartmentalization of hepatitis C virus in hepatocellular carcinoma tissue
2016
The New Equivocal
2015
Thyroid Hormone Regulation of Metabolism
2014 Standout
Aldehyde Dehydrogenase Activity of Breast Cancer Stem Cells Is Primarily Due To Isoform ALDH1A3 and Its Expression Is Predictive of Metastasis
2010
Hypoxia-inducible factor 1-dependent expression of platelet-derived growth factor B promotes lymphatic metastasis of hypoxic breast cancer cells
2012 StandoutNobel
Methylation of hypoxia-inducible factor (HIF)-1α by G9a/GLP inhibits HIF-1 transcriptional activity and cell migration
2018 StandoutNobel
Epithelial Plasticity: A Common Theme in Embryonic and Cancer Cells
2013 StandoutScience
HIF-1 regulates CD47 expression in breast cancer cells to promote evasion of phagocytosis and maintenance of cancer stem cells
2015 StandoutNobel
CAR T cell immunotherapy for human cancer
2018 StandoutScience
Immune Checkpoint Blockade in Cancer Therapy
2015 Standout
Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
2018 Standout
Immunogenic Cell Death in Cancer Therapy
2012 Standout
Works of Dorthe Grabau being referenced
Identification of Subtypes in Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer Reveals a Gene Signature Prognostic of Outcome
2010
The CD44+/CD24-phenotype is enriched in basal-like breast tumors
2008
The Sweden Cancerome Analysis Network - Breast (SCAN-B) Initiative: a large-scale multicenter infrastructure towards implementation of breast cancer genomic analyses in the clinical routine
2015
CD44 isoforms are heterogeneously expressed in breast cancer and correlate with tumor subtypes and cancer stem cell markers
2011
High-resolution genomic and expression analyses of copy number alterations in HER2-amplified breast cancer
2010
Global H3K27 trimethylation and EZH2 abundance in breast tumor subtypes
2012
Epidermal growth factor receptor (EGFR) and the estrogen receptor modulator amplified in breast cancer (AIB1) for predicting clinical outcome after adjuvant tamoxifen in breast cancer
2007
Determination of HER2 amplification in primary breast cancer using dual‐colour chromogenic in situ hybridization is comparable to fluorescence in situ hybridization: a European multicentre study involving 168 specimens
2010
Evidence for tissue factor phosphorylation and its correlation with protease‐activated receptor expression and the prognosis of primary breast cancer
2009
AIB1 is a predictive factor for tamoxifen response in premenopausal women
2009
Axillary lymph node micrometastases in invasive breast cancer: national figures on incidence and overall survival
2007
Targeting HMG-CoA reductase with statins in a window-of-opportunity breast cancer trial
2013
Serial monitoring of circulating tumor DNA in patients with primary breast cancer for detection of occult metastatic disease
2015
Immunohistochemical assessment of Ki67 with antibodies SP 6 and MIB 1 in primary breast cancer: a comparison of prognostic value and reproducibility
2014